- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Cubist Pharmaceuticals, Inc. (CBST)
by latest | most commented
-
FDA Calendar Updates: King Pharma, Pain Therapeutics
-
Buys for a Down Day
-
Does More Cash and Less Debt Equal Stock Market Gains?
-
Friday's Options Recap
-
Options Trader Friday Update: GE, TGT, XLI, CBST, HAL, DELL, XRT, CAL, JAVA
-
Teva Shows Cubist That Saving Lives Isn't Good Enough
-
Cubist and Alnylam, An Odd Partnership
-
2009: Positive Outlook for Biotech
-
2008 Stock Market: 51 Rays of Light
-
Eight Areas to Consider About This Market
-
Underdog Smallcaps: Potential Short Squeezes
-
Cash Is King: Accrual Earnings Stock Screen
-
Pfizer Should Buy Amgen or Wyeth - Credit Suisse
-
The Long Case for Targanta Therapeutics
-
Cubist Pharmaceuticals: Betting On Biotech
-
Staph Buzz Spotlights Cubist, Pfizer, Encysive
-
Biotech Day in Review: Eisai Buys Morphotek for $325 Million
-
Cubist Pharma Focuses On Abandoned Antibiotic Market